Deprecated: Creation of dynamic property cls_session::$session_data_table is deprecated in /www/sites/www.188bio.com/index/systems/cls_session.php on line 49
InvivoGen/Murine Anti-mCTLA4 mAb/mctla4-mab10-1188bio精品生物—专注于实验室精品爆款的电商平台 - 蚂蚁淘旗下精选188款生物医学科研用品
您好,欢迎您进入188进口试剂采购网网站! 服务热线:4000-520-616
蚂蚁淘商城 | 现货促销 | 科研狗 | 生物在线
产品资料

InvivoGen/Murine Anti-mCTLA4 mAb/mctla4-mab10-1

Murine Anti-mCTLA4 mAb

Anti-mCTLA4-mIgG2a InvivoFit™Unit sizeCat. codeDocsPrice
9D9-derived mouse monoclonal antibody against murine CTLA-4
1 mg
10 mg
mctla4-mab10-1
TDSMSDSDATA
¥4,586.00
Please contact our distributor
Add to favorite
  • About
  • Specifications
  • Contents
  • Details
  • Related products

Recombinant mouse mAb against murine CTLA-4 for in vivo use

Effect of Anti-CTLA4 on T cell functionEffect of Anti-CTLA4 on T cell activation

Anti-mCTLA4-mIgG2a InvivoFit™ is a mouse anti-mouse monoclonal antibody (mAb) featuring the variable region of the previously described anti-mCTLA-4 9D9 mAb [1] and a murine IgG2a constant region. The 9D9 mAb has a sequence that is 100% murine (constant and variable regions), ensuring minimal immunogenicity upon repeated injections into mice. This mAb targets murine cytotoxic T-lymphocyte-associated protein 4 (mCTLA-4) and blocks CTLA4-mediated negative signals downregulating T cell activation.  Thus, anti-mCTLA-4 mAb unleashes T cell activity [1, 2].Notably, the 9D9 mAb, along with most commercially available anti-mCTLA4 mAbs feature the IgG2b isotype which displays low antitumor activity in vivo [2]. To overcome this issue, Anti-mCTLA4-mIgG2a InvivoFit™ was generated by recombinant technology and features the murine IgG2a isotype, which mediates potent cytotoxic functions. Anti-mCTLA4-mIgG2a is provided in an InvivoFit grade, a high-quality standard specifically adapted to in vivo studies.

 

Key features of Anti-mCTLA4-mIgG2a InvivoFit™:

  • Sequence is 100% murine
  • Features the IgG2a isotype (associated with high antitumor activity)
  • Guaranteed sterile, endotoxin level < 1 EU/mg
  • Specifically designed for in vivo studies in mice
  • Low aggregation < 5%
  • Produced in both animal-free facilities and defined media

Anti-mCTLA4-mIgG2a InvivoFit™ is produced in Chinese hamster ovary (CHO) cells, purified by affinity chromatography with protein A, and it"s binding to mCTLA-4 is validated using ELISA.

 

References:

1. Selby MJ. et al., 2013. Anti-CTLA-4 antibodies of IgG2a isotype enhance antitumor activity through reduction of intratumoral regulatory T cells. Cancer Immunol Res. 1(1):32-42.2. Ribas A. & Wolchock J.D., 2018. Cancer immunotherapy using checkpoint blockade. Science. 359:1350-55.

Figures

Evaluation of Anti-mCTLA4-mIgG2a binding to mCTLA-4
Evaluation of Anti-mCTLA4-mIgG2a binding to mCTLA-4

ELISA binding of Anti-mCTLA4-mIgG2a InvivoFit™ to recombinant murine CTLA-4.

A dilution series of Anti-mCTLA4-mIgG2a InvivoFit™ and anti-mCTLA4 (9D9 clone) was used for the detection of coated mCTLA-4 antigen at 5  µg/ml. Detection of bound antibody was performed using an HRP‑conjugated anti‑murine κ-light chain secondary antibody.  HRP activity was assessed by a colorimetric assay using Tetramethylbenzidine (TMB) substrate. Optical density was measured at 490 nm. Data are shown as percentage absorbance.

Back to the top

Specifications

Specificity: Targets cells expressing murine CTLA-4

Formulation: Lyophilized from 0.2 μm filtered solution in 150 mM sodium chloride, 20 mM sodium phosphate buffer with 5% saccharose

Clonality: Monoclonal antibody

Isotype: Murine IgG2a, kappa

Source: CHO cells

Purity: Purified by affinity chromatography with protein A

Tested application: ELISA

Quality control:

  • Binding confirmed using ELISA
  • The complete sequence of this antibody has been verified
  • < 5% aggregates (confirmed by size exclusion chromatography)
  • Guaranteed sterile and <1 EU/mg (determined by the LAL assay)
Back to the top

Contents

Anti-mCTLA4-mIgG2a InvivoFit™ is provided sterile, endotoxin-free, azide-free and lyophilized.  

This product is available in two pack sizes:

  • mctla4-mab10-1​: 1 mg
  • mctla4-mab10-10​: 10 mg

 

room temperature Product is shipped at room temperature.

store Store lyophilized antibody at -20 °C.

stability Lyophilized product is stable for at least 1 year

Alert Avoid repeated freeze-thaw cycles.

Back to the top

Details

The cytotoxic T-lymphocyte-associated protein 4 (CTLA-4, also known as CD152) is an inhibitory receptor expressed on activated T lymphocytes. T-cell activation requires two signals. Signal 1 is delivered upon interaction of the T cell receptor (TCR) with antigenic peptides bound to major histocompatibility complex (MHC) molecules on antigen-presenting cells (APCs). Signal 2 is delivered upon interaction of the co-stimulatory receptor CD28 with the B7 family ligands, B7-1 (CD80) and B7-2 (CD86), on APCs.CTLA-4 is an immune checkpoint molecule upregulated upon T cell activation. It exerts competitive binding to CD28 ligands, thereby preventing T-cell overstimulation. CTLA-4 blockade with monoclonal antibodies (mAbs) has been used to treat patients with metastatic melanoma.

Back to the top

You may also need

Raji-hCTLA4 Cells

Human lymphoblast cells - ADCC CTLA-4 Target Cells

Anti-hCTLA4 isotype family

Family of antibodies against human CTLA-4

Mouse IgG2a Control

β-galactosidase antibody (isotype control) - Mouse IgG2a

新闻动态
行业前沿
技术文章
最新产品